Association of 25-hydroxyvitamin D levels with liver dysfunction and mortality in chronic liver disease

Liver International

Volumn 32, Issue 5, 2012, Pages 845-851

  Putz Bankuti, Csilla ^a   Pilz, Stefan ^a,b   Stojakovic, Tatjana ^a   Scharnagl, Hubert ^a   Pieber, Thomas R ^a   Trauner, Michael ^c   Obermayer Pietsch, Barbara ^a   Stauber, Rudolf E ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D;

ADULT; AGED; ARTICLE; CHRONIC LIVER DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DECOMPENSATED LIVER CIRRHOSIS; DISEASE ASSOCIATION; END STAGE LIVER DISEASE; FEMALE; FOLLOW UP; HUMAN; LIVER CIRRHOSIS; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTPATIENT DEPARTMENT; SURVIVAL; VITAMIN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; AUSTRIA; COMORBIDITY; END STAGE LIVER DISEASE; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84859461279     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2011.02735.x     Document Type: Article

References (34)

1. Bikle DD Vitamin D insufficiency/deficiency in gastrointestinal disorders. J Bone Miner Res 2007; 22: V50-4.
2. Holick MF Vitamin D deficiency. N Engl J Med 2007; 357: 266-81.
3. Townsend K, Evans KN, Campbell MJ, et al.Biological actions of extra-renal 25-hydroxyvitamin D-1-α-hydroxylase and implications for chemoprevention and treatment. J Steroid Biochem Mol Biol 2005; 97: 103-9.
4. Negrea LA, Slatopolsky E, Dusso AS 1, 25-dihydroxyvitamin D synthesis in rat liver microsomes. Horm Metab Res 1995; 27: 461-4.
5. Kazama JJ, Yamamoto T, Oya H, et al. A patient with severe hypercalcemia in multiple organ dysfunction syndrome: role of elevated circulating 1alpha, 25(OH)(2)VitD levels. J Bone Miner Res 2010; 25: 1455-9.
6. Bouillon R, Carmeliet G, Verlinden L, et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 2008; 29: 726-76.
7. Pilz S, Tomaschitz A, Obermayer-Pietsch B, Dobnig H, Pieber TR Epidemiology of vitamin D insufficiency and cancer mortality. Anticancer Res 2009; 29: 3699-704.
8. Pilz S, Tomaschitz A, Ritz E, Pieber TR Vitamin D status and arterial hypertension: a systematic review. Nat Rev Cardiol 2009; 6: 621-30.
9. Pilz S, Tomaschitz A, Drechsler C, Dekker JM, März W Vitamin D deficiency and myocardial diseases. Mol Nutr Food Res 2010; 54: 1103-13.
10. Shoenfeld N, Amital H, Shoenfeld Y The effect of melanism and vitamin D synthesis on the incidence of autoimmune disease. Nat Clin Pract Rheumatol 2009; 5: 99-105.
11. Yamshchikov AV, Desai NS, Blumberg HM, Tangpricha V Vitamin D for treatment and prevention of infectious diseases: a systematic review of randomized controlled trials. Endocr Pract 2009; 15: 438-49.
12. Autier P, Gandini S Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med 2007; 167: 1730-7.
13. Petta S, Cammà C, Scazzone C, et al. Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C. Hepatology 2010; 51: 1158-67.
14. Pappa HM, Bern E, Kamin D, Grand RJ Vitamin D status in gastrointestinal and liver disease. Curr Opin Gastroenterol 2008; 24: 176-83.
15. Duarte MP, Farias ML, Coelho HS, et al. Calcium-parathyroid hormone-vitamin D axis and metabolic bone disease in chronic viral liver disease. J Gastroenterol Hepatol 2001; 16: 1022-7.
16. Chen CC, Wang SS, Jeng FS, Lee SD Metabolic bone disease of liver cirrhosis: is it parallel to the clinical severity of cirrhosis? J Gastroenterol Hepatol 1996; 11: 417-21.
17. Arteh J, Narra S, Nair S Prevalence of vitamin D deficiency in chronic liver disease. Dig Dis Sci 2010; 55: 2624-8.
18. Fisher L, Fisher A Vitamin D and parathyroid hormone in outpatients with noncholestatic chronic liver disease. Clin Gastroenterol Hepatol 2007; 5: 513-20.
19. Bouillon R, Auwerx J, Dekeyser L, et al.Serum vitamin D metabolites and their binding protein in patients with liver cirrhosis. J Clin Endocrinol Metab 1984; 59: 86-9.
20. Masuda S, Okano T, Osawa K, et al.Concentrations of vitamin D-binding protein and vitamin D metabolites in plasma of patients with liver cirrhosis. J Nutr Sci Vitaminol (Tokyo) 1989; 35: 225-34.
21. Malham M, Jørgensen SP, Ott P, et al. Vitamin D deficiency in cirrhosis relates to liver dysfunction rather than aetiology. World J Gastroenterol 2011; 17: 922-5.
22. Miroliaee A, Nasiri-Toosi M, Khalilzadeh O, et al.Disturbances of parathyroid hormone-vitamin D axis in non-cholestatic chronic liver disease: a cross-sectional study. Hepatol Int 2010; 4: 634-40.
23. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-9.
24. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-470.
25. Zuniga S, Firrincieli D, Housset C, Chignard N Vitamin D and the vitamin D receptor in liver pathophysiology. Clin Res Hepatol Gastroenterol 2011; 35: 259-302.
26. Bitetto D, Fabris C, Falleti E, et al. Vitamin D and the risk of acute allograft rejection following human liver transplantation. Liver Int 2010; 30: 417-44.
27. Prietl B, Pilz S, Wolf M, et al. Vitamin D supplementation and regulatory T cells in apparently healthy subjects: vitamin D treatment for autoimmune diseases? Isr Med Assoc J 2010; 12: 136-9.
28. Bitetto D, Fattovich G, Fabris C, et al. Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C. Hepatology 2011; 53: 118-26.
29. Drocourt L, Ourlin JC, Pascussi JM, Maurel P, Vilarem MJ Expression of CYP3A4, CYP2B6, and CYP2C9 is regulated by the vitamin D receptor pathway in primary human hepatocytes. J Biol Chem 2002; 277: 25125-32.
30. Han S, Li T, Ellis E, Strom S, Chiang JY A novel bile acid-activated vitamin D receptor signaling in human hepatocytes. Mol Endocrinol 2010; 24: 1151-64.
31. Schmidt DR, Holmstrom SR, Fon Tacer K, et al.Regulation of bile acid synthesis by fat-soluble vitamins A and D. J Biol Chem 2010; 285: 14486-94.
32. Pilz S, Iodice S, Zittermann A, Grant WB, Gandini S Vitamin D status and mortality risk in CKD: a meta-analysis of prospective studies. Am J Kidney Dis 2011; 58: 374-382.
33. Pilz S, Tomaschitz A, März W, et al. Vitamin D, cardiovascular disease and mortality. Clin Endocrinol (Oxf) 2011; 75: 575-584.
34. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2011; 96: 1911-30.